학술논문
Rechallenge of afatinib for EGFR-mutated non-small cell lung cancer previously treated with osimertinib: a multicenter phase II trial protocol (REAL study)
Document Type
Article
Author
Source
In: Translational Lung Cancer Research . (Translational Lung Cancer Research, 30 June 2023, 12(6):1320-1327)
Subject
Language
English
ISSN
22264477
22186751
22186751